---
http_interactions:
- request:
    method: post
    uri: https://eds-api.ebscohost.com/authservice/rest/uidauth
    body:
      encoding: UTF-8
      string: |2
              {
                "UserId":"DUMMY_USER_ID",
                "Password":"DUMMY_PWD"
              }
    headers:
      Accept:
      - application/json
      Content-Type:
      - application/json
  response:
    status:
      code: 200
      message: OK
    headers:
      Cache-Control:
      - private
      Content-Length:
      - '128'
      Content-Type:
      - application/json; charset=utf-8
      Server:
      - Microsoft-IIS/7.5
      X-Aspnet-Version:
      - 4.0.30319
      X-Powered-By:
      - ASP.NET
      Date:
      - Mon, 24 Oct 2016 19:54:58 GMT
    body:
      encoding: UTF-8
      string: '{"AuthToken":"ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0","AuthTimeout":"1800"}'
    http_version: 
  recorded_at: Mon, 24 Oct 2016 19:54:59 GMT
- request:
    method: get
    uri: http://eds-api.ebscohost.com/edsapi/rest/createsession?guest=n&profile=wsapi
    body:
      encoding: UTF-8
      string: ''
    headers:
      X-Authenticationtoken:
      - ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0
      Accept:
      - application/xml
  response:
    status:
      code: 200
      message: OK
    headers:
      Cache-Control:
      - private
      Content-Length:
      - '279'
      Content-Type:
      - application/xml; charset=utf-8
      Server:
      - Microsoft-IIS/7.5
      X-Sessiontoken:
      - f23796ef-26e8-4e9d-b754-401e6aa8a69d.uxX/9/HMGfN4XF+oChCc1bzpIqAg12j1r3tGpKTiLJg=
      X-Authenticationtoken:
      - ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0
      X-Msg-Correlid:
      - b16d7a1e-9fb4-4919-aea9-c74b47c349c8
      X-Aspnet-Version:
      - 4.0.30319
      X-Powered-By:
      - ASP.NET
      Date:
      - Mon, 24 Oct 2016 19:54:59 GMT
    body:
      encoding: UTF-8
      string: <CreateSessionResponseMessage xmlns="http://epnet.com/webservices/EbscoApi/Contracts"
        xmlns:i="http://www.w3.org/2001/XMLSchema-instance"><SessionToken>f23796ef-26e8-4e9d-b754-401e6aa8a69d.uxX/9/HMGfN4XF+oChCc1bzpIqAg12j1r3tGpKTiLJg=</SessionToken></CreateSessionResponseMessage>
    http_version: 
  recorded_at: Mon, 24 Oct 2016 19:54:59 GMT
- request:
    method: get
    uri: http://eds-api.ebscohost.com/edsapi/rest/search?highlight=y&query=AND,cancer&resultsperpage=10&searchmode=all&view=detailed
    body:
      encoding: UTF-8
      string: ''
    headers:
      X-Authenticationtoken:
      - ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0
      Accept:
      - application/xml
      X-Sessiontoken:
      - f23796ef-26e8-4e9d-b754-401e6aa8a69d.uxX/9/HMGfN4XF+oChCc1bzpIqAg12j1r3tGpKTiLJg=
  response:
    status:
      code: 200
      message: OK
    headers:
      Cache-Control:
      - private
      Content-Length:
      - '127595'
      Content-Type:
      - application/xml; charset=utf-8
      Server:
      - Microsoft-IIS/7.5
      X-Sessiontoken:
      - f23796ef-26e8-4e9d-b754-401e6aa8a69d.uxX/9/HMGfN4XF+oChCc1bzpIqAg12j1r3tGpKTiLJg=
      X-Authenticationtoken:
      - ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0
      X-Msg-Correlid:
      - 1c1fa3ca-0553-4458-a4ee-6183c0439a2b
      X-Aspnet-Version:
      - 4.0.30319
      X-Powered-By:
      - ASP.NET
      Date:
      - Mon, 24 Oct 2016 19:55:00 GMT
    body:
      encoding: UTF-8
      string: '<SearchResponseMessageGet xmlns="http://epnet.com/webservices/EbscoApi/Contracts"
        xmlns:i="http://www.w3.org/2001/XMLSchema-instance"><SearchRequestGet><QueryString>query-1=AND,cancer&amp;sort=relevance&amp;includefacets=y&amp;searchmode=all&amp;autosuggest=n&amp;view=detailed&amp;resultsperpage=10&amp;pagenumber=1&amp;highlight=y</QueryString><SearchCriteriaWithActions><QueriesWithAction><QueryWithAction><Query><BooleanOperator>AND</BooleanOperator><Term>cancer</Term></Query><RemoveAction>removequery(1)</RemoveAction></QueryWithAction></QueriesWithAction></SearchCriteriaWithActions></SearchRequestGet><SearchResult><Statistics><TotalHits>1000956</TotalHits><TotalSearchTime>664</TotalSearchTime><Databases><Database><Id>bth</Id><Label>Business
        Source Complete</Label><Status>0</Status><Hits>61279</Hits></Database><Database><Id>a9h</Id><Label/><Status>0</Status><Hits>906230</Hits></Database><Database><Id>lpr</Id><Label>Index
        to Legal Periodicals Retrospective: 1908-1981 (H.W. Wilson)</Label><Status>0</Status><Hits>113</Hits></Database><Database><Id>edslex</Id><Label>LexisNexis
        Academic: Law Reviews</Label><Status>0</Status><Hits>1812</Hits></Database><Database><Id>edshol</Id><Label>HeinOnline</Label><Status>0</Status><Hits>349</Hits></Database><Database><Id>edsglt</Id><Label>InfoTrac
        LegalTrac</Label><Status>0</Status><Hits>1705</Hits></Database><Database><Id>edsjsr</Id><Label>JSTOR
        Journals</Label><Status>0</Status><Hits>29462</Hits></Database><Database><Id>ir00629a</Id><Label>FLASH
        (Institutional Repository)</Label><Status>0</Status><Hits>6</Hits></Database></Databases></Statistics><Data><RecordFormat>EP
        Display</RecordFormat><Records><Record><ResultId>1</ResultId><Header><DbId>bth</DbId><DbLabel>Business
        Source Complete</DbLabel><An>108395096</An><RelevancyScore>2174</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=bth&amp;AN=108395096</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>WORK
        CONTINUATION WHILE TREATED FOR BREAST &lt;highlight&gt;CANCER&lt;/highlight&gt;:
        THE ROLE OF WORKPLACE ACCOMMODATIONS.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22NEUMARK%2C+DAVID%22"&gt;NEUMARK, DAVID&lt;/searchLink&gt;&lt;relatesTo&gt;1,2,3&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22BRADLEY%2C+CATHY+J%2E%22"&gt;BRADLEY,
        CATHY J.&lt;/searchLink&gt;&lt;relatesTo&gt;4&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22HENRY%2C+MIGUEL%22"&gt;HENRY, MIGUEL&lt;/searchLink&gt;&lt;relatesTo&gt;5&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22DAHMAN%2C+BASSAM%22"&gt;DAHMAN,
        BASSAM&lt;/searchLink&gt;&lt;relatesTo&gt;6&lt;/relatesTo&gt;&lt;i&gt; bdahman@vcu.edu&lt;/i&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22ILR+Review%22"&gt;ILR Review&lt;/searchLink&gt;. Aug2015,
        Vol. 68 Issue 4, p916-954. 39p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22RESEARCH%22"&gt;RESEARCH&lt;/searchLink&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="DE" term="%22Breast+cancer%22"&gt;Breast &lt;highlight&gt;cancer&lt;/highlight&gt;&lt;/searchLink&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="DE" term="%22PATIENTS%22"&gt;PATIENTS&lt;/searchLink&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="DE" term="%22Women+with+disabilities+--+Employment%22"&gt;Women
        with disabilities -- Employment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="DE" term="%22Breast+cancer+--+Treatment%22"&gt;Breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        -- Treatment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode="DE" term="%22Employees%22"&gt;Employees&lt;/searchLink&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="DE" term="%22WORKLOAD%22"&gt;WORKLOAD&lt;/searchLink&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="DE" term="%22Working+hours%22"&gt;Working hours&lt;/searchLink&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="DE" term="%22People+with+disabilities%22"&gt;People
        with disabilities&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode="DE"
        term="%22EMPLOYMENT%22"&gt;EMPLOYMENT&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>Given
        the short- and long-term disabilities associated with breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        and its treatment, the authors investigate the influence of workplace accommodations
        on the employment and hours worked of women newly diagnosed with breast &lt;highlight&gt;cancer&lt;/highlight&gt;.
        Accommodations that allow women to work fewer hours or that ease the burden
        of work could also generate health benefits by reducing workplace demands
        and allowing women more time to tend to treatment needs and recovery. In prior
        research, the authors found modest labor supply impacts on employment for
        this group of women. Evidence from this study suggests that some accommodations
        are associated with fewer hours worked, while some are associated with higher
        employment or hours. In addition, some of the accommodations that may affect
        hours of work--sometimes positively and sometimes negatively-- are associated
        with positive health benefits. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of ILR Review is the property of Sage Publications Inc. and its content may
        not be copied or emailed to multiple sites or posted to a listserv without
        the copyright holder''s express written permission. However, users may print,
        download, or email articles for individual use. This abstract may be abridged.
        No warranty is given about the accuracy of the copy. Users should refer to
        the original published version of the material for the full abstract.&lt;/i&gt;
        (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.1177/0019793915586974</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>39</PageCount><StartPage>916</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>RESEARCH</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Breast
        cancer</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>PATIENTS</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Women
        with disabilities -- Employment</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Breast
        cancer -- Treatment</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Employees</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>WORKLOAD</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Working
        hours</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>People
        with disabilities</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>EMPLOYMENT</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>WORK
        CONTINUATION WHILE TREATED FOR BREAST CANCER: THE ROLE OF WORKPLACE ACCOMMODATIONS.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>NEUMARK,
        DAVID</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>BRADLEY,
        CATHY J.</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>HENRY,
        MIGUEL</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>DAHMAN,
        BASSAM</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>08</M><Text>Aug2015</Text><Type>published</Type><Y>2015</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>00197939</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>68</Value></Number><Number><Type>issue</Type><Value>4</Value></Number></Numbering><Titles><Title><TitleFull>ILR
        Review</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>2</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>116969066</An><RelevancyScore>2162</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=116969066</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>On
        the contribution of psychological flexibility to predict adjustment to breast
        &lt;highlight&gt;cancer&lt;/highlight&gt;.</Data></Item><Item><Name>TitleAlt</Name><Label>Alternate
        Title</Label><Group>TiAlt</Group><Data>Contribución de la flexibilidad psicológica
        en la predicción del distrés psicológico en pacientes con cáncer de mama.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22Montiel%2C+Carmen+Berrocal%22"&gt;Montiel, Carmen
        Berrocal&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; carmen.berrocalmontiel@med.unipi.it&lt;/i&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Moya%2C+Teresa+Rivas%22"&gt;Moya,
        Teresa Rivas&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Venditti%2C+Francesca%22"&gt;Venditti,
        Francesca&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22Bernini%2C+Olivia%22"&gt;Bernini, Olivia&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22Psicothema%22"&gt;Psicothema&lt;/searchLink&gt;. aug2016,
        Vol. 28 Issue 3, p266-271. 6p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Breast+cancer+--+Patients%22"&gt;Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Patients&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Breast+cancer+--+Treatment%22"&gt;Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Treatment&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Adaptability+%28Psychology%29%22"&gt;Adaptability
        (Psychology)&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Anxiety%22"&gt;Anxiety&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink
        fieldCode="DE" term="%22Mental+depression%22"&gt;Mental depression&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Distress+%28Psychology%29%22"&gt;Distress
        (Psychology)&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract
        (English)</Label><Group>Ab</Group><Data>Background: This study explored the
        contribution of Psychological Flexibility (PF) to predict adjustment to breast
        &lt;highlight&gt;cancer&lt;/highlight&gt;. Method: Sixtyfour females with
        breast &lt;highlight&gt;cancer&lt;/highlight&gt; completed self-report measures
        of PF and adjustment (anxiety, depression, negative and positive affect) at
        baseline, and forty-two patients returned for assessment six months later.
        Results: Higher flexibility at baseline significantly contributed to predict
        lower anxiety, depression and negative affect at follow-up. The effect sizes
        ranged from moderate to large. Conclusions: Results provide evidence for targeting
        PF to prevent enhanced psychological distress in patients with breast &lt;highlight&gt;cancer&lt;/highlight&gt;,
        and add to a growing body of research supporting PF as a common protective
        factor across different contexts and populations. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>Abstract</Name><Label>Abstract
        (Spanish)</Label><Group>Ab</Group><Data>Antecedentes: este estudio explora
        el grado de contribución de la Flexibilidad Psicológica (FP) en el pronóstico
        de diversos indicadores de adaptación al cáncer de mama. Método: 64 mujeres
        con cáncer de mama completaron medidas de FP, ansiedad, depresión, afecto
        negativo y positivo en un primer momento (TI), y 42 de ellas repitieron la
        evaluación seis meses después (T2). Resultados: los resultados indican que
        la FP en TI contribuye significativamente en la predicción de ansiedad, depresión
        y afecto negativo en T2, con tamaños del efecto que oscilan entre moderado
        y grande. Elevados niveles de FP se asocian significativamente con niveles
        más bajos de distrés psicológico. Conclusiones: los resultados apoyan que
        la FP es un factor protector de niveles excesivos de distrés en pacientes
        con cáncer de mama. Estos resultados se suman al creciente cuerpo de evidencias
        que sugiere que la FP es un factor general de protección de la salud mental,
        transversal a diferentes contextos y poblaciones. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of Psicothema is the property of Colegio Oficial de Psicologos del Principado
        de Asturias and its content may not be copied or emailed to multiple sites
        or posted to a listserv without the copyright holder''s express written permission.
        However, users may print, download, or email articles for individual use.
        This abstract may be abridged. No warranty is given about the accuracy of
        the copy. Users should refer to the original published version of the material
        for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.7334/psicothema2015.271</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>6</PageCount><StartPage>266</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Breast
        cancer -- Patients</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Breast
        cancer -- Treatment</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Adaptability
        (Psychology)</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Anxiety</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Mental
        depression</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Distress
        (Psychology)</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>On
        the contribution of psychological flexibility to predict adjustment to breast
        cancer.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>Montiel,
        Carmen Berrocal</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Moya,
        Teresa Rivas</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Venditti,
        Francesca</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Bernini,
        Olivia</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>08</M><Text>aug2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>02149915</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>28</Value></Number><Number><Type>issue</Type><Value>3</Value></Number></Numbering><Titles><Title><TitleFull>Psicothema</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>3</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>117242119</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=117242119</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>Spheres
        from cervical &lt;highlight&gt;cancer&lt;/highlight&gt; cells display stemness
        and &lt;highlight&gt;cancer&lt;/highlight&gt; drug resistance.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22HUAN+LIU%22"&gt;HUAN LIU&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22HAIJUAN+WANG%22"&gt;HAIJUAN WANG&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22CHUNXIAO+LI%22"&gt;CHUNXIAO LI&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22TINGTING+ZHANG%22"&gt;TINGTING
        ZHANG&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22XITING+MENG%22"&gt;XITING MENG&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22YING+ZHANG%22"&gt;YING ZHANG&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;i&gt;
        zyandzm@163.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode="AR" term="%22HAILI+QIAN%22"&gt;HAILI
        QIAN&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; qianhaili001@163.com&lt;/i&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22Oncology+Letters%22"&gt;Oncology Letters&lt;/searchLink&gt;.
        Sep2016, Vol. 12 Issue 3, p2184-2188. 5p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Cervical+cancer+--+Treatment%22"&gt;Cervical
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Treatment&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Cancer+cells%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        cells&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE" term="%22Cervical+cancer+--+Patients%22"&gt;Cervical
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Patients&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Drug+resistance+in+cancer+cells%22"&gt;Drug
        resistance in &lt;highlight&gt;cancer&lt;/highlight&gt; cells&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Polymerase+chain+reaction%22"&gt;Polymerase
        chain reaction&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>Cervical
        &lt;highlight&gt;cancer&lt;/highlight&gt; is one of the most common gynecological
        malignant tumors and is the cause of a serious health problem worldwide. An
        increasing amount of evidence has shown that &lt;highlight&gt;cancer&lt;/highlight&gt;
        stem cells (CSCs) are present in tumors, and that these CSCs may be responsible
        for tumor metastasis and relapse. The present study aimed to identify and
        characterize a CSC population from the CaSki cell line. First, a stem cell
        culture medium was used to selectively expand the &lt;highlight&gt;cancer&lt;/highlight&gt;
        stem-like cell spheres, and the putative stemness markers, Oct4 and Sox2,
        were identified. These markers were all highly expressed in the CaSki sphere-forming
        cells. Next, target region amplified polymorphism-polymerase chain reaction
        was performed and the CaSki sphere-forming cells were found to exhibit higher
        telomerase activity than the CaSki control cells cultured in non-stem cell
        medium. Using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
        (4-sulfophenyl)-2H-tetrazolium assay, it was found that the CaSki sphere-forming
        cells were more resistant to chemotherapeutic drugs than the control CaSki
        cells. Using the tumor invasive assay, it was shown that the CaSki sphere-forming
        cells were more invasive than the control CaSki cells. These characteristics
        all suggested that the tumor sphere-forming cells mirrored the acknowledged
        CSC phenotypes. Overall, the use of a suspended sphere culture of CaSki cells
        may be an easy and feasible approach for enriching &lt;highlight&gt;cancer&lt;/highlight&gt;
        stem-like cells in cervical &lt;highlight&gt;cancer&lt;/highlight&gt; research.
        [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of Oncology Letters is the property of Spandidos Publications UK Ltd and its
        content may not be copied or emailed to multiple sites or posted to a listserv
        without the copyright holder''s express written permission. However, users
        may print, download, or email articles for individual use. This abstract may
        be abridged. No warranty is given about the accuracy of the copy. Users should
        refer to the original published version of the material for the full abstract.&lt;/i&gt;
        (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.3892/ol.2016.4893</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>5</PageCount><StartPage>2184</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Cervical
        cancer -- Treatment</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        cells</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cervical
        cancer -- Patients</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Drug
        resistance in cancer cells</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Polymerase
        chain reaction</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>Spheres
        from cervical cancer cells display stemness and cancer drug resistance.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>HUAN
        LIU</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>HAIJUAN
        WANG</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>CHUNXIAO
        LI</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>TINGTING
        ZHANG</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>XITING
        MENG</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>YING
        ZHANG</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>HAILI
        QIAN</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>09</M><Text>Sep2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>17921074</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>12</Value></Number><Number><Type>issue</Type><Value>3</Value></Number></Numbering><Titles><Title><TitleFull>Oncology
        Letters</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>4</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>118338916</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=118338916</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>Targeted
        &lt;highlight&gt;Cancer&lt;/highlight&gt; Therapy: Vital Oncogenes and a New
        Molecular Genetic Paradigm for &lt;highlight&gt;Cancer&lt;/highlight&gt; Initiation
        Progression and Treatment.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22Willis%2C+Rudolph+E%2E%22"&gt;Willis, Rudolph E.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt;
        rwillis@oncostembio.com&lt;/i&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22International+Journal+of+Molecular+Sciences%22"&gt;International
        Journal of Molecular Sciences&lt;/searchLink&gt;. Sep2016, Vol. 17 Issue 9,
        p1-23. 23p.</Data></Item><Item><Name>Subject</Name><Label>Subject Terms</Label><Group>Su</Group><Data>*&lt;searchLink
        fieldCode="DE" term="%22Cancer+treatment%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        treatment&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE" term="%22Cancer+invasiveness%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        invasiveness&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Cancer+--+Molecular+aspects%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        -- Molecular aspects&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Cancer+genetics%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        genetics&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE" term="%22Carcinogenesis%22"&gt;Carcinogenesis&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Cancer+cells%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        cells&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>It
        has been declared repeatedly that &lt;highlight&gt;cancer&lt;/highlight&gt;
        is a result of molecular genetic abnormalities. However, there has been no
        working model describing the specific functional consequences of the deranged
        genomic processes that result in the initiation and propagation of the &lt;highlight&gt;cancer&lt;/highlight&gt;
        process during carcinogenesis. We no longer need to question whether or not
        &lt;highlight&gt;cancer&lt;/highlight&gt; arises as a result of a molecular
        genetic defect within the &lt;highlight&gt;cancer&lt;/highlight&gt; cell.
        The legitimate questions are: how and why? This article reviews the preeminent
        data on &lt;highlight&gt;cancer&lt;/highlight&gt; molecular genetics and subsequently
        proposes that the sentinel event in &lt;highlight&gt;cancer&lt;/highlight&gt;
        initiation is the aberrant production of fused transcription activators with
        new molecular properties within normal tissue stem cells. This results in
        the production of vital oncogenes with dysfunctional gene activation transcription
        properties, which leads to dysfunctional gene regulation, the aberrant activation
        of transduction pathways, chromosomal breakage, activation of driver oncogenes,
        reactivation of stem cell transduction pathways and the activation of genes
        that result in the hallmarks of &lt;highlight&gt;cancer&lt;/highlight&gt;.
        Furthermore, a novel holistic molecular genetic model of &lt;highlight&gt;cancer&lt;/highlight&gt;
        initiation and progression is presented along with a new paradigm for the
        approach to personalized targeted &lt;highlight&gt;cancer&lt;/highlight&gt;
        therapy, clinical monitoring and &lt;highlight&gt;cancer&lt;/highlight&gt;
        diagnosis. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of International Journal of Molecular Sciences is the property of MDPI Publishing
        and its content may not be copied or emailed to multiple sites or posted to
        a listserv without the copyright holder''s express written permission. However,
        users may print, download, or email articles for individual use. This abstract
        may be abridged. No warranty is given about the accuracy of the copy. Users
        should refer to the original published version of the material for the full
        abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.3390/ijms17091552</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>23</PageCount><StartPage>1</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Cancer
        treatment</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        invasiveness</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        -- Molecular aspects</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        genetics</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Carcinogenesis</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        cells</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>Targeted
        Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer
        Initiation Progression and Treatment.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>Willis,
        Rudolph E.</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>09</M><Text>Sep2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>14220067</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>17</Value></Number><Number><Type>issue</Type><Value>9</Value></Number></Numbering><Titles><Title><TitleFull>International
        Journal of Molecular Sciences</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>5</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>117669540</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=117669540</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>Relationship
        of Predicted Risk of Developing Invasive Breast &lt;highlight&gt;Cancer&lt;/highlight&gt;,
        as Assessed with Three Models, and Breast &lt;highlight&gt;Cancer&lt;/highlight&gt;
        Mortality among Breast &lt;highlight&gt;Cancer&lt;/highlight&gt; Patients.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22Sherman%2C+Mark+E%2E%22"&gt;Sherman, Mark E.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt;
        ShermanM@mail.nih.gov&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode="AR" term="%22Ichikawa%2C+Laura%22"&gt;Ichikawa,
        Laura&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22Pfeiffer%2C+Ruth+M%2E%22"&gt;Pfeiffer, Ruth M.&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Miglioretti%2C+Diana+L%2E%22"&gt;Miglioretti,
        Diana L.&lt;/searchLink&gt;&lt;relatesTo&gt;2,4&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22Kerlikowske%2C+Karla%22"&gt;Kerlikowske, Karla&lt;/searchLink&gt;&lt;relatesTo&gt;5&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Tice%2C+Jeffery%22"&gt;Tice, Jeffery&lt;/searchLink&gt;&lt;relatesTo&gt;6&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Vacek%2C+Pamela+M%2E%22"&gt;Vacek,
        Pamela M.&lt;/searchLink&gt;&lt;relatesTo&gt;7&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22Gierach%2C+Gretchen+L%2E%22"&gt;Gierach, Gretchen
        L.&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22PLoS+ONE%22"&gt;PLoS ONE&lt;/searchLink&gt;. 8/25/2016,
        Vol. 11 Issue 8, p1-15. 15p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Breast+cancer+--+Risk+factors%22"&gt;Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Risk factors&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Cancer+invasiveness%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        invasiveness&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Cancer+--+Mortality%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        -- Mortality&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Disease+incidence%22"&gt;Disease incidence&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Health+counseling%22"&gt;Health
        counseling&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>Purpose:  Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; risk prediction models are used
        to plan clinical trials and counsel women; however, relationships of predicted
        risks of breast &lt;highlight&gt;cancer&lt;/highlight&gt; incidence and prognosis
        after breast &lt;highlight&gt;cancer&lt;/highlight&gt; diagnosis are unknown.
        Methods:  Using largely pre-diagnostic information from the Breast &lt;highlight&gt;Cancer&lt;/highlight&gt;
        Surveillance Consortium (BCSC) for 37,939 invasive breast &lt;highlight&gt;cancers&lt;/highlight&gt;
        (1996–2007), we estimated 5-year breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        risk (&lt;1%; 1–1.66%; ≥1.67%) with three models: BCSC 1-year risk model (BCSC-1;
        adapted to 5-year predictions); Breast &lt;highlight&gt;Cancer&lt;/highlight&gt;
        Risk Assessment Tool (BCRAT); and BCSC 5-year risk model (BCSC-5). Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt;-specific mortality post-diagnosis
        (range: 1–13 years; median: 5.4–5.6 years) was related to predicted risk of
        developing breast &lt;highlight&gt;cancer&lt;/highlight&gt; using unadjusted
        Cox proportional hazards models, and in age-stratified (35–44; 45–54; 55–69;
        70–89 years) models adjusted for continuous age, BCSC registry, calendar period,
        income, mode of presentation, stage and treatment. Mean age at diagnosis was
        60 years. Results:  Of 6,021 deaths, 2,993 (49.7%) were ascribed to breast
        &lt;highlight&gt;cancer&lt;/highlight&gt;. In unadjusted case-only analyses,
        predicted breast &lt;highlight&gt;cancer&lt;/highlight&gt; risk ≥1.67% versus
        &lt;1.0% was associated with lower risk of breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        death; BCSC-1: hazard ratio (HR) = 0.82 (95% CI = 0.75–0.90); BCRAT: HR =
        0.72 (95% CI = 0.65–0.81) and BCSC-5: HR = 0.84 (95% CI = 0.75–0.94). Age-stratified,
        adjusted models showed similar, although mostly non-significant HRs. Among
        women ages 55–69 years, HRs approximated 1.0. Generally, higher predicted
        risk was inversely related to percentages of &lt;highlight&gt;cancers&lt;/highlight&gt;
        with unfavorable prognostic characteristics, especially among women 35–44
        years. Conclusions:  Among cases assessed with three models, higher predicted
        risk of developing breast &lt;highlight&gt;cancer&lt;/highlight&gt; was not
        associated with greater risk of breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        death; thus, these models would have limited utility in planning studies to
        evaluate breast &lt;highlight&gt;cancer&lt;/highlight&gt; mortality reduction
        strategies. Further, when offering women counseling, it may be useful to note
        that high predicted risk of developing breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        does not imply that if &lt;highlight&gt;cancer&lt;/highlight&gt; develops
        it will behave aggressively. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of PLoS ONE is the property of Public Library of Science and its content may
        not be copied or emailed to multiple sites or posted to a listserv without
        the copyright holder''s express written permission. However, users may print,
        download, or email articles for individual use. This abstract may be abridged.
        No warranty is given about the accuracy of the copy. Users should refer to
        the original published version of the material for the full abstract.&lt;/i&gt;
        (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.1371/journal.pone.0160966</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>15</PageCount><StartPage>1</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Breast
        cancer -- Risk factors</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        invasiveness</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        -- Mortality</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Disease
        incidence</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Health
        counseling</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>Relationship
        of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three
        Models, and Breast Cancer Mortality among Breast Cancer Patients.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>Sherman,
        Mark E.</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Ichikawa,
        Laura</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Pfeiffer,
        Ruth M.</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Miglioretti,
        Diana L.</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Kerlikowske,
        Karla</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Tice,
        Jeffery</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Vacek,
        Pamela M.</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Gierach,
        Gretchen L.</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>25</D><M>08</M><Text>8/25/2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>19326203</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>11</Value></Number><Number><Type>issue</Type><Value>8</Value></Number></Numbering><Titles><Title><TitleFull>PLoS
        ONE</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>6</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>117687084</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=117687084</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>Prognostic
        impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression
        in &lt;highlight&gt;cancer&lt;/highlight&gt; cells and tumor infiltrating
        lymphocytes in colorectal &lt;highlight&gt;cancer&lt;/highlight&gt;.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22Yaqi+Li%22"&gt;Yaqi Li&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Lei+Liang%22"&gt;Lei Liang&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Weixing+Dai%22"&gt;Weixing Dai&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Guoxiang+Cai%22"&gt;Guoxiang Cai&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Ye+Xu%22"&gt;Ye Xu&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Xinxiang+Li%22"&gt;Xinxiang Li&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Qingguo+Li%22"&gt;Qingguo Li&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;i&gt;
        oncosurgeonli@sohu.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode="AR"
        term="%22Sanjun+Cai%22"&gt;Sanjun Cai&lt;/searchLink&gt;&lt;relatesTo&gt;1,2&lt;/relatesTo&gt;&lt;i&gt;
        caisanjunsh@163.com&lt;/i&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22Molecular+Cancer%22"&gt;Molecular &lt;highlight&gt;Cancer&lt;/highlight&gt;&lt;/searchLink&gt;.
        8/24/2016, Vol. 15, p1-15. 15p. 1 Diagram, 3 Charts, 3 Graphs.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Programmed+cell+death+1+receptors%22"&gt;Programmed
        cell death 1 receptors&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Cancer+cells%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt; cells&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Lymphocytes%22"&gt;Lymphocytes&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Colon+cancer%22"&gt;Colon &lt;highlight&gt;cancer&lt;/highlight&gt;&lt;/searchLink&gt;</Data></Item><Item><Name>SubjectProduct</Name><Label>Reviews
        &amp; Products</Label><Group>Su</Group><Data>&lt;searchLink fieldCode="PS"
        term="%22Cancer+Genome+Atlas%2C+The+%28Book%29%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        Genome Atlas, The (Book)&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>Background:
        Colorectal &lt;highlight&gt;cancer&lt;/highlight&gt; (CRC) is 3rd most commonly
        diagnosed &lt;highlight&gt;cancer&lt;/highlight&gt; in males and the second
        in females. PD-1/PD-L1 axis, as an immune checkpoint, is up-regulated in many
        tumors and their microenvironment. However, the prognostic value of PD-1/PD-L1
        in CRC remains unclear. Methods: The &lt;highlight&gt;Cancer&lt;/highlight&gt;
        Genome Atlas (TCGA) database (N = 356) and Fudan University Shanghai &lt;highlight&gt;Cancer&lt;/highlight&gt;
        Center (FUSCC) cohort of patients (N = 276) were adopted to analyze the prognostic
        value of PD-L1 in colorectal tumor cells (TCs) and of PD-1 in tumor infiltrating
        cells (TILs) for CRC. Subgroup analyses were conducted in FUSCC cohort according
        to patients'' status of mismatch repair. Results: In TCGA cohort, the cut-off
        values of PD-1 and PD-L1 expression were determined by X-tile program, which
        were 4.40 and 2.92, respectively. Kaplan-Meier analysis indicated that higher
        PD-1 and PD-L1 expressions correlated with better OS (P = 0.032 and P = 0.002,
        respectively). In FUSCC cohort, expressions of PD-1 on TILs and PD-L1 on TCs
        were analyzed separately by immunohistochemistry (IHC) staining based on a
        TMA sample (N = 276) and revealed that both TILs-PD-1 and TCs-PD-L1 were associated
        with OS (P = 0.006 and P = 0.002, respectively) and DFS (P = 0.025 and P =
        0.004, respectively) of CRC patients. Multivariate Cox regression analysis
        indicated TILs- PD-1 was an independent prognostic factor both for OS and
        DFS of CRC patients (P &lt; 0.05). Subgroup analyses showed that TILs-PD-1
        was an independent prognostic factor for both OS and DFS in CRC patients in
        MSSproficient subgroup (P &lt; 0.05), while neither of them correlated with
        OS or DFS in MSS-deficient subgroup (P &gt; 0.05). Conclusions: Higher expressions
        of PD-1 and PD-L1 correlates with better prognosis of CRC patients. TILs-PD-1
        is an independent prognostic factor for OS and DFS of CRC patients, especially
        for MMR-proficient subgroup. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of Molecular &lt;highlight&gt;Cancer&lt;/highlight&gt; is the property of
        BioMed Central and its content may not be copied or emailed to multiple sites
        or posted to a listserv without the copyright holder''s express written permission.
        However, users may print, download, or email articles for individual use.
        This abstract may be abridged. No warranty is given about the accuracy of
        the copy. Users should refer to the original published version of the material
        for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.1186/s12943-016-0539-x</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>15</PageCount><StartPage>1</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Cancer
        Genome Atlas, The (Book)</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Programmed
        cell death 1 receptors</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        cells</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Lymphocytes</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Colon
        cancer</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>Prognostic
        impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression
        in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>Yaqi
        Li</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Lei
        Liang</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Weixing
        Dai</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Guoxiang
        Cai</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Ye
        Xu</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Xinxiang
        Li</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Qingguo
        Li</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Sanjun
        Cai</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>24</D><M>08</M><Text>8/24/2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>14764598</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>15</Value></Number></Numbering><Titles><Title><TitleFull>Molecular
        Cancer</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>7</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>118321028</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=118321028</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>MicroRNA-210
        interacts with FBXO31 to regulate &lt;highlight&gt;cancer&lt;/highlight&gt;
        proliferation cell cycle and migration in human breast &lt;highlight&gt;cancer&lt;/highlight&gt;.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22Dayue+Liu%22"&gt;Dayue Liu&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Haoming+Xia%22"&gt;Haoming Xia&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Fang+Wang%22"&gt;Fang Wang&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Cui+Chen%22"&gt;Cui Chen&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Jianting+Long%22"&gt;Jianting
        Long&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;i&gt; longjt2@mail.sysu.edu.cn&lt;/i&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22OncoTargets+%26+Therapy%22"&gt;OncoTargets &amp; Therapy&lt;/searchLink&gt;.
        Aug2016, Vol. 9, p5245-5255. 11p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Breast+cancer+--+Research%22"&gt;Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Research&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22MicroRNA%22"&gt;MicroRNA&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Cancer+cells+--+Proliferation%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        cells -- Proliferation&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Cancer+cell+migration%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        cell migration&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Human+cell+cycle%22"&gt;Human cell cycle&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>Background:
        In this study, we investigated the functional correlation between microRNA-210
        (miR-210) and gene of F-box protein 31 (FBXO31) in regulating breast &lt;highlight&gt;cancer&lt;/highlight&gt;.
        Methods: Dual-luciferase assay and quantitative real-time polymerase chain
        reaction were used to investigate the binding of miR-210 with FBXO31 and their
        expression patterns in breast &lt;highlight&gt;cancer&lt;/highlight&gt;. miR-210
        was inhibited in breast &lt;highlight&gt;cancer&lt;/highlight&gt; T47D and
        MCF-7 cells to assess its effect on &lt;highlight&gt;cancer&lt;/highlight&gt;
        proliferation, cell cycle progression, and migration. FBXO31 was also downregulated
        in breast &lt;highlight&gt;cancer&lt;/highlight&gt; cells to examine its effect
        on miR-210-mediated breast &lt;highlight&gt;cancer&lt;/highlight&gt; regulation.
        The interaction between miR-210 and FBXO31 was further investigated by examining
        the effect of overexpressing miR-210 on FBXO31-induced suppression of breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; proliferation. Results: FBXO31 was
        the downstream target gene of miR-210 in breast &lt;highlight&gt;cancer&lt;/highlight&gt;.
        miR-210 and FBXO31 are inversely expressed in breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        cell lines. miR-210 downregulation reduced &lt;highlight&gt;cancer&lt;/highlight&gt;
        progression, induced cell cycle arrest, and inhibited &lt;highlight&gt;cancer&lt;/highlight&gt;
        migration in T47D and MCF-7 cells. Tumor suppression by miR-210 downregulation
        was reversed by downregulating FBXO31. In FBXO31-overexpressed breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        cells, upregulating miR-210 also reversed the tumorsuppressive effect of FBXO31
        on breast &lt;highlight&gt;cancer&lt;/highlight&gt; proliferation. Conclusion:
        Our work demonstrated that the expression pattern and tumor regulatory functions
        of miR-210 and FBXO31 are inversely correlated in breast &lt;highlight&gt;cancer&lt;/highlight&gt;.
        [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of OncoTargets &amp; Therapy is the property of Dove Medical Press Ltd and
        its content may not be copied or emailed to multiple sites or posted to a
        listserv without the copyright holder''s express written permission. However,
        users may print, download, or email articles for individual use. This abstract
        may be abridged. No warranty is given about the accuracy of the copy. Users
        should refer to the original published version of the material for the full
        abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.2147/OTT.S110969</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>11</PageCount><StartPage>5245</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Breast
        cancer -- Research</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>MicroRNA</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        cells -- Proliferation</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        cell migration</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Human
        cell cycle</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>MicroRNA-210
        interacts with FBXO31 to regulate cancer proliferation cell cycle and migration
        in human breast cancer.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>Dayue
        Liu</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Haoming
        Xia</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Fang
        Wang</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Cui
        Chen</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Jianting
        Long</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>08</M><Text>Aug2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>11786930</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>9</Value></Number></Numbering><Titles><Title><TitleFull>OncoTargets
        &amp; Therapy</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>8</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>118285599</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=118285599</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>"My
        &lt;highlight&gt;cancer&lt;/highlight&gt; is not my deepest concern": life
        course disruption influencing patient pathways and health care needs among
        persons living with colorectal &lt;highlight&gt;cancer&lt;/highlight&gt;.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22Salamonsen%2C+Anita%22"&gt;Salamonsen, Anita&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt;
        anita.salamonsen@uit.no&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode="AR"
        term="%22Kiil%2C+Mona+A%2E%22"&gt;Kiil, Mona A.&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Kristoffersen%2C+Agnete+Egilsdatter%22"&gt;Kristoffersen,
        Agnete Egilsdatter&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Stub%2C+Trine%22"&gt;Stub, Trine&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22Berntsen%2C+Gro+R%2E%22"&gt;Berntsen,
        Gro R.&lt;/searchLink&gt;&lt;relatesTo&gt;1,3&lt;/relatesTo&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22Patient+Preference+%26+Adherence%22"&gt;Patient Preference
        &amp; Adherence&lt;/searchLink&gt;. Aug2016, Vol. 10, p1591-1600. 10p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Colon+cancer+--+Patients%22"&gt;Colon
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Patients&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Guidelines%22"&gt;Guidelines&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Rectal+cancer+--+Diagnosis%22"&gt;Rectal
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Diagnosis&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Mental+depression%22"&gt;Mental
        depression&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode="DE" term="%22Medical+care+--+Norway%22"&gt;Medical
        care -- Norway&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>Background:
        The concept of "patient pathways" in &lt;highlight&gt;cancer&lt;/highlight&gt;
        care is most commonly understood as clinical pathways, operationalized as
        standardized packages of health care based on guidelines for the condition
        in question. In this understanding, patient pathways do not address multimorbidity
        or patient experiences and preferences. This study explored patient pathways
        understood as the individual and cultural life course, which includes both
        life and health events. The overall aim was to contribute to supportive and
        targeted &lt;highlight&gt;cancer&lt;/highlight&gt; care. Materials and methods:
        Nine Norwegian patients recently diagnosed with rectal &lt;highlight&gt;cancer&lt;/highlight&gt;
        Tumor-Node-Metastasis stage I-III participated in qualitative interviews,
        five times over 1 year. Five patients later participated in a workshop where
        they made illustrations of and discussed patient pathways. Results: Patient
        pathways including both health and life events were illustrated and described
        as complex and circular. Stress, anxiety, and depression caused by life events
        had significant disruptive effects and influenced patient-defined health care
        needs. The participants experienced the Norwegian public health service as
        focused on hospital-based standardized &lt;highlight&gt;cancer&lt;/highlight&gt;
        care. They expressed unmet health care needs in terms of emotional and practical
        support in their everyday life with &lt;highlight&gt;cancer&lt;/highlight&gt;,
        and some turned to complementary and alternative medicine. Conclusion: This
        study suggests that acknowledging life course disruption before &lt;highlight&gt;cancer&lt;/highlight&gt;
        diagnosis may have significant relevance for understanding complex patient
        pathways and individual health care needs. Approaching patient pathways as
        individual and socially constructed may contribute important knowledge to
        support targeted &lt;highlight&gt;cancer&lt;/highlight&gt; care. [ABSTRACT
        FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of Patient Preference &amp; Adherence is the property of Dove Medical Press
        Ltd and its content may not be copied or emailed to multiple sites or posted
        to a listserv without the copyright holder''s express written permission.
        However, users may print, download, or email articles for individual use.
        This abstract may be abridged. No warranty is given about the accuracy of
        the copy. Users should refer to the original published version of the material
        for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.2147/PPA.S108422</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>10</PageCount><StartPage>1591</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Colon
        cancer -- Patients</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Guidelines</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Rectal
        cancer -- Diagnosis</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Mental
        depression</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Medical
        care -- Norway</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>"My
        cancer is not my deepest concern": life course disruption influencing patient
        pathways and health care needs among persons living with colorectal cancer.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>Salamonsen,
        Anita</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Kiil,
        Mona A.</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Kristoffersen,
        Agnete Egilsdatter</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Stub,
        Trine</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>Berntsen,
        Gro R.</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>08</M><Text>Aug2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>1177889X</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>10</Value></Number></Numbering><Titles><Title><TitleFull>Patient
        Preference &amp; Adherence</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>9</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>116924770</An><RelevancyScore>2152</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=116924770</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>&lt;highlight&gt;Cancer&lt;/highlight&gt;
        of unknown primary ultimately diagnosed as male breast &lt;highlight&gt;cancer&lt;/highlight&gt;:
        A rare case report.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22RIGAKOS%2C+GEORGIOS%22"&gt;RIGAKOS, GEORGIOS&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22VAKOS%2C+AMANDA%22"&gt;VAKOS,
        AMANDA&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22PAPADOPOULOS%2C+SOTIRIOS%22"&gt;PAPADOPOULOS, SOTIRIOS&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt;
        sotpapado@gmail.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode="AR" term="%22VERNADOU%2C+ANASTASIA%22"&gt;VERNADOU,
        ANASTASIA&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22TSIMPIDAKIS%2C+ANTONIOS%22"&gt;TSIMPIDAKIS, ANTONIOS&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22PAPACHRISTOU%2C+DIONYSIOS%22"&gt;PAPACHRISTOU,
        DIONYSIOS&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22RAZIS%2C+EVANGELIA%22"&gt;RAZIS, EVANGELIA&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22Molecular+%26+Clinical+Oncology%22"&gt;Molecular &amp;
        Clinical Oncology&lt;/searchLink&gt;. Aug2016, Vol. 5 Issue 2, p263-266. 4p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Breast+cancer+in+men%22"&gt;Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; in men&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Immunohistochemistry%22"&gt;Immunohistochemistry&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Breast+cancer+--+Treatment%22"&gt;Breast
        &lt;highlight&gt;cancer&lt;/highlight&gt; -- Treatment&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>&lt;highlight&gt;Cancers&lt;/highlight&gt;
        of unknown primary (CUP) constitute a significant diagnostic and therapeutic
        challenge for clinicians and a frequent cause of &lt;highlight&gt;cancer&lt;/highlight&gt;-related
        mortality in Western countries. Immunohistochemistry assays are commonly used
        to identify the primary &lt;highlight&gt;cancer&lt;/highlight&gt;, but fail
        in approximately one-third of cases. The identification of the possible origin
        of CUP is crucial, as it may help select the appropriate treatment options.
        We herein present the case of a 54-year-old male patient, who presented with
        lower back pain in June, 2013. Following a thorough investigation, the clinical
        and pathological findings could not identify the primary &lt;highlight&gt;cancer&lt;/highlight&gt;,
        leading towards a misdiagnosis. Ultimately, microRNA testing of the resected
        spine lesion was able to identify the primary tumor as male breast &lt;highlight&gt;cancer&lt;/highlight&gt;
        and allow for optimal treatment of the patient. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of Molecular &amp; Clinical Oncology is the property of Spandidos Publications
        UK Ltd and its content may not be copied or emailed to multiple sites or posted
        to a listserv without the copyright holder''s express written permission.
        However, users may print, download, or email articles for individual use.
        This abstract may be abridged. No warranty is given about the accuracy of
        the copy. Users should refer to the original published version of the material
        for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.3892/mco.2016.912</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>4</PageCount><StartPage>263</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Breast
        cancer in men</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Immunohistochemistry</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Breast
        cancer -- Treatment</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>Cancer
        of unknown primary ultimately diagnosed as male breast cancer: A rare case
        report.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>RIGAKOS,
        GEORGIOS</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>VAKOS,
        AMANDA</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>PAPADOPOULOS,
        SOTIRIOS</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>VERNADOU,
        ANASTASIA</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>TSIMPIDAKIS,
        ANTONIOS</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>PAPACHRISTOU,
        DIONYSIOS</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>RAZIS,
        EVANGELIA</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>08</M><Text>Aug2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>20499450</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>5</Value></Number><Number><Type>issue</Type><Value>2</Value></Number></Numbering><Titles><Title><TitleFull>Molecular
        &amp; Clinical Oncology</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record><Record><ResultId>10</ResultId><Header><DbId>a9h</DbId><DbLabel/><An>117840971</An><RelevancyScore>2148</RelevancyScore><PubType>Academic
        Journal</PubType><PubTypeId>academicJournal</PubTypeId></Header><PLink>http://0-search.ebscohost.com.lawpac.lawnet.fordham.edu/login.aspx?direct=true&amp;site=eds-live&amp;db=a9h&amp;AN=117840971</PLink><FullText><Links><Link><Type>pdflink</Type></Link></Links><Text><Availability>0</Availability></Text></FullText><Items><Item><Name>Title</Name><Label>Title</Label><Group>Ti</Group><Data>Side
        population cells from long-term passage non-small cell lung &lt;highlight&gt;cancer&lt;/highlight&gt;
        cells display loss of &lt;highlight&gt;cancer&lt;/highlight&gt; stem cell-like
        properties and chemoradioresistance.</Data></Item><Item><Name>Author</Name><Label>Authors</Label><Group>Au</Group><Data>&lt;searchLink
        fieldCode="AR" term="%22HAO+GU%22"&gt;HAO GU&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22XIN-YU+WU%22"&gt;XIN-YU WU&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22RUI-TAI+FAN%22"&gt;RUI-TAI FAN&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt;
        fanruitai@hotmail.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode="AR" term="%22XIN+WANG%22"&gt;XIN
        WANG&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink
        fieldCode="AR" term="%22YOU-ZHONG+GUO%22"&gt;YOU-ZHONG GUO&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br
        /&gt;&lt;searchLink fieldCode="AR" term="%22RUI+WANG%22"&gt;RUI WANG&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;</Data></Item><Item><Name>TitleSource</Name><Label>Source</Label><Group>Src</Group><Data>&lt;searchLink
        fieldCode="JN" term="%22Oncology+Letters%22"&gt;Oncology Letters&lt;/searchLink&gt;.
        Oct2016, Vol. 12 Issue 4, p2886-2893. 8p.</Data></Item><Item><Name>Subject</Name><Label>Subject
        Terms</Label><Group>Su</Group><Data>*&lt;searchLink fieldCode="DE" term="%22Non-small-cell+lung+carcinoma%22"&gt;Non-small-cell
        lung carcinoma&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE"
        term="%22Cancer+stem+cells%22"&gt;&lt;highlight&gt;Cancer&lt;/highlight&gt;
        stem cells&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode="DE" term="%22Doxorubicin%22"&gt;Doxorubicin&lt;/searchLink&gt;&lt;br
        /&gt;*&lt;searchLink fieldCode="DE" term="%22Chemotherapy+%28Cancer%29%22"&gt;Chemotherapy
        (&lt;highlight&gt;Cancer&lt;/highlight&gt;)&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink
        fieldCode="DE" term="%22Primary+cells%22"&gt;Primary cells&lt;/searchLink&gt;</Data></Item><Item><Name>Abstract</Name><Label>Abstract</Label><Group>Ab</Group><Data>The
        side population (SP) assay is a widely used method for isolating stem cell-like
        cells from &lt;highlight&gt;cancer&lt;/highlight&gt; cell lines and primary
        cells. The &lt;highlight&gt;cancer&lt;/highlight&gt; cells used in different
        laboratories have been passaged for different generations. Emerging evidence
        revealed that repeated passaging of cell lines for multiple generations frequently
        leads to change of characteristics. Thus, it is worth investigating the effects
        of repeated passaging on the biological and functional properties of the enriched
        SP fraction from early- and late-passage cells. The present study reports
        that the &lt;highlight&gt;cancer&lt;/highlight&gt; stem cell (CSC) characteristics,
        including increased frequency of tumor-initiating and self-renewal capacity,
        and resistance to the chemotherapy agent doxorubicin and ionizing radiation,
        was diminished in SP cells from late-passage non-small cell lung &lt;highlight&gt;cancer&lt;/highlight&gt;
        (NSCLC) cells. This finding revealed that the SP from long-term passage NSCLC
        cells was not consistently enriched for stem cell-like &lt;highlight&gt;cancer&lt;/highlight&gt;
        cells, and low-passage cell lines and primary &lt;highlight&gt;cancer&lt;/highlight&gt;
        cells are therefore recommended in the CSCs field. [ABSTRACT FROM AUTHOR]</Data></Item><Item><Name>AbstractSuppliedCopyright</Name><Label/><Group>Ab</Group><Data>&lt;i&gt;Copyright
        of Oncology Letters is the property of Spandidos Publications UK Ltd and its
        content may not be copied or emailed to multiple sites or posted to a listserv
        without the copyright holder''s express written permission. However, users
        may print, download, or email articles for individual use. This abstract may
        be abridged. No warranty is given about the accuracy of the copy. Users should
        refer to the original published version of the material for the full abstract.&lt;/i&gt;
        (Copyright applies to all Abstracts.)</Data></Item></Items><RecordInfo><BibRecord><BibEntity><Identifiers><Identifier><Type>doi</Type><Value>10.3892/ol.2016.4934</Value></Identifier></Identifiers><Languages><Language><Code>eng</Code><Text>English</Text></Language></Languages><PhysicalDescription><Pagination><PageCount>8</PageCount><StartPage>2886</StartPage></Pagination></PhysicalDescription><Subjects><Subject><SubjectFull>Non-small-cell
        lung carcinoma</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Cancer
        stem cells</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Doxorubicin</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Chemotherapy
        (Cancer)</SubjectFull><Type>general</Type></Subject><Subject><SubjectFull>Primary
        cells</SubjectFull><Type>general</Type></Subject></Subjects><Titles><Title><TitleFull>Side
        population cells from long-term passage non-small cell lung cancer cells display
        loss of cancer stem cell-like properties and chemoradioresistance.</TitleFull><Type>main</Type></Title></Titles></BibEntity><BibRelationships><HasContributorRelationships><HasContributor><PersonEntity><Name><NameFull>HAO
        GU</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>XIN-YU
        WU</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>RUI-TAI
        FAN</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>XIN
        WANG</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>YOU-ZHONG
        GUO</NameFull></Name></PersonEntity></HasContributor><HasContributor><PersonEntity><Name><NameFull>RUI
        WANG</NameFull></Name></PersonEntity></HasContributor></HasContributorRelationships><IsPartOfRelationships><IsPartOf><BibEntity><Dates><Date><D>01</D><M>10</M><Text>Oct2016</Text><Type>published</Type><Y>2016</Y></Date></Dates><Identifiers><Identifier><Type>issn-print</Type><Value>17921074</Value></Identifier></Identifiers><Numbering><Number><Type>volume</Type><Value>12</Value></Number><Number><Type>issue</Type><Value>4</Value></Number></Numbering><Titles><Title><TitleFull>Oncology
        Letters</TitleFull><Type>main</Type></Title></Titles></BibEntity></IsPartOf></IsPartOfRelationships></BibRelationships></BibRecord></RecordInfo></Record></Records></Data><AvailableFacets><AvailableFacet><Id>SourceType</Id><Label>Source
        Type</Label><AvailableFacetValues><AvailableFacetValue><Value>Academic Journals</Value><Count>871086</Count><AddAction>addfacetfilter(SourceType:Academic
        Journals)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Magazines</Value><Count>70894</Count><AddAction>addfacetfilter(SourceType:Magazines)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>News</Value><Count>25040</Count><AddAction>addfacetfilter(SourceType:News)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Reviews</Value><Count>6169</Count><AddAction>addfacetfilter(SourceType:Reviews)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Reports</Value><Count>3633</Count><AddAction>addfacetfilter(SourceType:Reports)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Books</Value><Count>1963</Count><AddAction>addfacetfilter(SourceType:Books)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Primary
        Source Documents</Value><Count>17</Count><AddAction>addfacetfilter(SourceType:Primary
        Source Documents)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>SubjectEDS</Id><Label>Subject</Label><AvailableFacetValues><AvailableFacetValue><Value>cancer</Value><Count>80606</Count><AddAction>addfacetfilter(SubjectEDS:cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>research</Value><Count>61845</Count><AddAction>addfacetfilter(SubjectEDS:research)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>breast
        cancer</Value><Count>55714</Count><AddAction>addfacetfilter(SubjectEDS:breast
        cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        cells</Value><Count>54395</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        cells)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        patients</Value><Count>53876</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        patients)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        treatment</Value><Count>52814</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        treatment)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>tumors</Value><Count>47838</Count><AddAction>addfacetfilter(SubjectEDS:tumors)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>gene
        expression</Value><Count>40562</Count><AddAction>addfacetfilter(SubjectEDS:gene
        expression)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>metastasis</Value><Count>36101</Count><AddAction>addfacetfilter(SubjectEDS:metastasis)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>apoptosis</Value><Count>33114</Count><AddAction>addfacetfilter(SubjectEDS:apoptosis)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>antineoplastic
        agents</Value><Count>33008</Count><AddAction>addfacetfilter(SubjectEDS:antineoplastic
        agents)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>chemotherapy
        (cancer)</Value><Count>29300</Count><AddAction>addfacetfilter(SubjectEDS:chemotherapy
        \(cancer\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>prostate
        cancer</Value><Count>28472</Count><AddAction>addfacetfilter(SubjectEDS:prostate
        cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>colon
        cancer</Value><Count>25608</Count><AddAction>addfacetfilter(SubjectEDS:colon
        cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>diagnosis</Value><Count>25585</Count><AddAction>addfacetfilter(SubjectEDS:diagnosis)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>oncology</Value><Count>24802</Count><AddAction>addfacetfilter(SubjectEDS:oncology)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        -- radiotherapy</Value><Count>23741</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        -- radiotherapy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>radiotherapy</Value><Count>23722</Count><AddAction>addfacetfilter(SubjectEDS:radiotherapy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>patients</Value><Count>22431</Count><AddAction>addfacetfilter(SubjectEDS:patients)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>clinical
        trials</Value><Count>21493</Count><AddAction>addfacetfilter(SubjectEDS:clinical
        trials)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        invasiveness</Value><Count>20969</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        invasiveness)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>carcinogenesis</Value><Count>20648</Count><AddAction>addfacetfilter(SubjectEDS:carcinogenesis)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>drug
        therapy</Value><Count>20145</Count><AddAction>addfacetfilter(SubjectEDS:drug
        therapy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>prognosis</Value><Count>19221</Count><AddAction>addfacetfilter(SubjectEDS:prognosis)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>research
        article</Value><Count>17680</Count><AddAction>addfacetfilter(SubjectEDS:research
        article)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>mutation
        (biology)</Value><Count>17651</Count><AddAction>addfacetfilter(SubjectEDS:mutation
        \(biology\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>lungs
        -- cancer</Value><Count>17030</Count><AddAction>addfacetfilter(SubjectEDS:lungs
        -- cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>immunohistochemistry</Value><Count>16567</Count><AddAction>addfacetfilter(SubjectEDS:immunohistochemistry)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>biochemical
        markers</Value><Count>16347</Count><AddAction>addfacetfilter(SubjectEDS:biochemical
        markers)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>squamous
        cell carcinoma</Value><Count>16276</Count><AddAction>addfacetfilter(SubjectEDS:squamous
        cell carcinoma)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>outcome
        assessment (medical care)</Value><Count>16067</Count><AddAction>addfacetfilter(SubjectEDS:outcome
        assessment \(medical care\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cell
        proliferation</Value><Count>15977</Count><AddAction>addfacetfilter(SubjectEDS:cell
        proliferation)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cell
        lines</Value><Count>15782</Count><AddAction>addfacetfilter(SubjectEDS:cell
        lines)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>proteins</Value><Count>15196</Count><AddAction>addfacetfilter(SubjectEDS:proteins)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>mice
        as laboratory animals</Value><Count>15144</Count><AddAction>addfacetfilter(SubjectEDS:mice
        as laboratory animals)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>diseases</Value><Count>14512</Count><AddAction>addfacetfilter(SubjectEDS:diseases)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>medical
        research</Value><Count>13609</Count><AddAction>addfacetfilter(SubjectEDS:medical
        research)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        research</Value><Count>12903</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        research)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>t cells</Value><Count>12703</Count><AddAction>addfacetfilter(SubjectEDS:t
        cells)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cellular
        signal transduction</Value><Count>12702</Count><AddAction>addfacetfilter(SubjectEDS:cellular
        signal transduction)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>liver
        -- cancer</Value><Count>12625</Count><AddAction>addfacetfilter(SubjectEDS:liver
        -- cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>tumors
        -- growth</Value><Count>12176</Count><AddAction>addfacetfilter(SubjectEDS:tumors
        -- growth)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>quality
        of life</Value><Count>11917</Count><AddAction>addfacetfilter(SubjectEDS:quality
        of life)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>medical
        care</Value><Count>11714</Count><AddAction>addfacetfilter(SubjectEDS:medical
        care)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>melanoma</Value><Count>11488</Count><AddAction>addfacetfilter(SubjectEDS:melanoma)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        -- diagnosis</Value><Count>11482</Count><AddAction>addfacetfilter(SubjectEDS:cancer
        -- diagnosis)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>therapeutics</Value><Count>11480</Count><AddAction>addfacetfilter(SubjectEDS:therapeutics)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>letters
        to the editor</Value><Count>11446</Count><AddAction>addfacetfilter(SubjectEDS:letters
        to the editor)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cervical
        cancer</Value><Count>11397</Count><AddAction>addfacetfilter(SubjectEDS:cervical
        cancer)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>surgery</Value><Count>11370</Count><AddAction>addfacetfilter(SubjectEDS:surgery)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>Journal</Id><Label>Publication</Label><AvailableFacetValues><AvailableFacetValue><Value>plos
        one</Value><Count>25704</Count><AddAction>addfacetfilter(Journal:plos one)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>international
        journal of radiation oncology, biology, physics</Value><Count>17582</Count><AddAction>addfacetfilter(Journal:international
        journal of radiation oncology\, biology\, physics)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>proceedings
        of the national academy of sciences of the united states of america</Value><Count>12524</Count><AddAction>addfacetfilter(Journal:proceedings
        of the national academy of sciences of the united states of america)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>lancet</Value><Count>8604</Count><AddAction>addfacetfilter(Journal:lancet)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>wall
        street journal - eastern edition</Value><Count>5906</Count><AddAction>addfacetfilter(Journal:wall
        street journal - eastern edition)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>science</Value><Count>4644</Count><AddAction>addfacetfilter(Journal:science)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>the
        british medical journal</Value><Count>3784</Count><AddAction>addfacetfilter(Journal:the
        british medical journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cancer
        causes &amp; control</Value><Count>3153</Count><AddAction>addfacetfilter(Journal:cancer
        causes &amp; control)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>bioworld
        today</Value><Count>3102</Count><AddAction>addfacetfilter(Journal:bioworld
        today)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>environmental
        health perspectives</Value><Count>2643</Count><AddAction>addfacetfilter(Journal:environmental
        health perspectives)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>american
        journal of public health</Value><Count>2554</Count><AddAction>addfacetfilter(Journal:american
        journal of public health)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>massachusetts
        lawyers weekly</Value><Count>224</Count><AddAction>addfacetfilter(Journal:massachusetts
        lawyers weekly)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>journal
        of law, medicine &amp; ethics</Value><Count>106</Count><AddAction>addfacetfilter(Journal:journal
        of law\, medicine &amp; ethics)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>j.l.
        med. &amp; ethics</Value><Count>72</Count><AddAction>addfacetfilter(Journal:j.l.
        med. &amp; ethics)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>american
        journal of law &amp; medicine</Value><Count>57</Count><AddAction>addfacetfilter(Journal:american
        journal of law &amp; medicine)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>aba
        journal</Value><Count>36</Count><AddAction>addfacetfilter(Journal:aba journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>health
        matrix</Value><Count>35</Count><AddAction>addfacetfilter(Journal:health matrix)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>issues
        in law &amp; medicine</Value><Count>34</Count><AddAction>addfacetfilter(Journal:issues
        in law &amp; medicine)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>medical
        trial technique quarterly</Value><Count>28</Count><AddAction>addfacetfilter(Journal:medical
        trial technique quarterly)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>food
        and drug law journal</Value><Count>25</Count><AddAction>addfacetfilter(Journal:food
        and drug law journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>journal
        of health care law &amp; policy</Value><Count>21</Count><AddAction>addfacetfilter(Journal:journal
        of health care law &amp; policy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>health
        law journal</Value><Count>19</Count><AddAction>addfacetfilter(Journal:health
        law journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>albany
        law journal of science &amp; technology</Value><Count>18</Count><AddAction>addfacetfilter(Journal:albany
        law journal of science &amp; technology)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>minnesota
        law review</Value><Count>18</Count><AddAction>addfacetfilter(Journal:minnesota
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>harvard
        law review</Value><Count>17</Count><AddAction>addfacetfilter(Journal:harvard
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>legislative
        history of the heart disease , cancer, and stroke amendments of 1965 : p.l.
        89-239 : 79 stat. 926 : october 6, 1965.</Value><Count>15</Count><AddAction>addfacetfilter(Journal:legislative
        history of the heart disease \, cancer\, and stroke amendments of 1965 \:
        p.l. 89-239 \: 79 stat. 926 \: october 6\, 1965.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>vanderbilt
        law review</Value><Count>15</Count><AddAction>addfacetfilter(Journal:vanderbilt
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>depaul
        law review</Value><Count>14</Count><AddAction>addfacetfilter(Journal:depaul
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>fordham
        urban law journal</Value><Count>14</Count><AddAction>addfacetfilter(Journal:fordham
        urban law journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>seton
        hall legislative journal</Value><Count>14</Count><AddAction>addfacetfilter(Journal:seton
        hall legislative journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>georgetown
        law journal</Value><Count>13</Count><AddAction>addfacetfilter(Journal:georgetown
        law journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>michigan
        law review</Value><Count>13</Count><AddAction>addfacetfilter(Journal:michigan
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>yale
        law journal</Value><Count>12</Count><AddAction>addfacetfilter(Journal:yale
        law journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>depaul
        journal of health care law</Value><Count>11</Count><AddAction>addfacetfilter(Journal:depaul
        journal of health care law)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>journal
        of law and policy</Value><Count>11</Count><AddAction>addfacetfilter(Journal:journal
        of law and policy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cardozo
        law review</Value><Count>10</Count><AddAction>addfacetfilter(Journal:cardozo
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>insurance
        counsel journal</Value><Count>10</Count><AddAction>addfacetfilter(Journal:insurance
        counsel journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>missouri
        law review</Value><Count>10</Count><AddAction>addfacetfilter(Journal:missouri
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>regulation
        of cancer-causing food additives - time for a change</Value><Count>10</Count><AddAction>addfacetfilter(Journal:regulation
        of cancer-causing food additives - time for a change)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>washington
        university journal of law &amp; policy</Value><Count>10</Count><AddAction>addfacetfilter(Journal:washington
        university journal of law &amp; policy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>wisconsin
        law review</Value><Count>9</Count><AddAction>addfacetfilter(Journal:wisconsin
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>catholic
        university law review</Value><Count>8</Count><AddAction>addfacetfilter(Journal:catholic
        university law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>hofstra
        law review</Value><Count>8</Count><AddAction>addfacetfilter(Journal:hofstra
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        york university law review</Value><Count>8</Count><AddAction>addfacetfilter(Journal:new
        york university law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>southern
        california law review</Value><Count>8</Count><AddAction>addfacetfilter(Journal:southern
        california law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>albany
        law review</Value><Count>4</Count><AddAction>addfacetfilter(Journal:albany
        law review)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        york state bar journal</Value><Count>4</Count><AddAction>addfacetfilter(Journal:new
        york state bar journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>columbia
        journal of environmental law</Value><Count>3</Count><AddAction>addfacetfilter(Journal:columbia
        journal of environmental law)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>family
        law quarterly</Value><Count>3</Count><AddAction>addfacetfilter(Journal:family
        law quarterly)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>food
        drug cosmetic law journal</Value><Count>3</Count><AddAction>addfacetfilter(Journal:food
        drug cosmetic law journal)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>Publisher</Id><Label>Publisher</Label><AvailableFacetValues><AvailableFacetValue><Value>elsevier
        science</Value><Count>187594</Count><AddAction>addfacetfilter(Publisher:elsevier
        science)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>wiley-blackwell</Value><Count>84286</Count><AddAction>addfacetfilter(Publisher:wiley-blackwell)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>springer
        science &amp; business media b.v.</Value><Count>70559</Count><AddAction>addfacetfilter(Publisher:springer
        science &amp; business media b.v.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>taylor
        &amp; francis ltd</Value><Count>35951</Count><AddAction>addfacetfilter(Publisher:taylor
        &amp; francis ltd)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>oxford
        university press / usa</Value><Count>32807</Count><AddAction>addfacetfilter(Publisher:oxford
        university press / usa)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>academic
        press inc.</Value><Count>31027</Count><AddAction>addfacetfilter(Publisher:academic
        press inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>john
        wiley &amp; sons, inc.</Value><Count>16319</Count><AddAction>addfacetfilter(Publisher:john
        wiley &amp; sons\, inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>bmj
        publishing group</Value><Count>13412</Count><AddAction>addfacetfilter(Publisher:bmj
        publishing group)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>american
        chemical society</Value><Count>11039</Count><AddAction>addfacetfilter(Publisher:american
        chemical society)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>national
        academy of sciences</Value><Count>10870</Count><AddAction>addfacetfilter(Publisher:national
        academy of sciences)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>lancet</Value><Count>8604</Count><AddAction>addfacetfilter(Publisher:lancet)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>lippincott
        williams &amp; wilkins</Value><Count>7821</Count><AddAction>addfacetfilter(Publisher:lippincott
        williams &amp; wilkins)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>dow
        jones &amp; company inc</Value><Count>7062</Count><AddAction>addfacetfilter(Publisher:dow
        jones &amp; company inc)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>time
        inc.</Value><Count>6993</Count><AddAction>addfacetfilter(Publisher:time inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>british
        medical association</Value><Count>6812</Count><AddAction>addfacetfilter(Publisher:british
        medical association)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>thomson
        reuters</Value><Count>5906</Count><AddAction>addfacetfilter(Publisher:thomson
        reuters)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>advanstar
        communications inc.</Value><Count>4720</Count><AddAction>addfacetfilter(Publisher:advanstar
        communications inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>american
        association for the advancement of science</Value><Count>4342</Count><AddAction>addfacetfilter(Publisher:american
        association for the advancement of science)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>marketline,
        a progressive digital media business</Value><Count>3516</Count><AddAction>addfacetfilter(Publisher:marketline\,
        a progressive digital media business)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>reed
        business information limited</Value><Count>2879</Count><AddAction>addfacetfilter(Publisher:reed
        business information limited)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>american
        public health association</Value><Count>2863</Count><AddAction>addfacetfilter(Publisher:american
        public health association)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>ieee</Value><Count>2503</Count><AddAction>addfacetfilter(Publisher:ieee)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>crain
        communications inc. (mi)</Value><Count>1897</Count><AddAction>addfacetfilter(Publisher:crain
        communications inc. \(mi\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>superintendent
        of documents</Value><Count>1665</Count><AddAction>addfacetfilter(Publisher:superintendent
        of documents)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>rogers
        media inc.</Value><Count>1635</Count><AddAction>addfacetfilter(Publisher:rogers
        media inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>us
        news &amp; world report, l.p.</Value><Count>1554</Count><AddAction>addfacetfilter(Publisher:us
        news &amp; world report\, l.p.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>haymarket
        media, inc.</Value><Count>1535</Count><AddAction>addfacetfilter(Publisher:haymarket
        media\, inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>world
        scientific publishing company</Value><Count>1424</Count><AddAction>addfacetfilter(Publisher:world
        scientific publishing company)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>media
        source, inc.</Value><Count>1343</Count><AddAction>addfacetfilter(Publisher:media
        source\, inc.)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>newsweek
        llc</Value><Count>1302</Count><AddAction>addfacetfilter(Publisher:newsweek
        llc)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cambridge
        university press</Value><Count>1142</Count><AddAction>addfacetfilter(Publisher:cambridge
        university press)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>scientific
        american</Value><Count>966</Count><AddAction>addfacetfilter(Publisher:scientific
        american)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>consumers
        union</Value><Count>886</Count><AddAction>addfacetfilter(Publisher:consumers
        union)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>prometheus
        global media, llc</Value><Count>845</Count><AddAction>addfacetfilter(Publisher:prometheus
        global media\, llc)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>pwxyz
        llc</Value><Count>742</Count><AddAction>addfacetfilter(Publisher:pwxyz llc)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>economist
        newspaper limited</Value><Count>732</Count><AddAction>addfacetfilter(Publisher:economist
        newspaper limited)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>advantage
        business media</Value><Count>720</Count><AddAction>addfacetfilter(Publisher:advantage
        business media)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>health
        forum</Value><Count>697</Count><AddAction>addfacetfilter(Publisher:health
        forum)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>the dolan
        media holding company, a delaware corporation</Value><Count>442</Count><AddAction>addfacetfilter(Publisher:the
        dolan media holding company\, a delaware corporation)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>incisive
        media</Value><Count>231</Count><AddAction>addfacetfilter(Publisher:incisive
        media)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>american
        bar association</Value><Count>130</Count><AddAction>addfacetfilter(Publisher:american
        bar association)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>west
        information publishing group</Value><Count>12</Count><AddAction>addfacetfilter(Publisher:west
        information publishing group)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>dissertation
        abstracts international</Value><Count>9</Count><AddAction>addfacetfilter(Publisher:dissertation
        abstracts international)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>flash:
        the fordham law archive of scholarship and history</Value><Count>6</Count><AddAction>addfacetfilter(Publisher:flash\:
        the fordham law archive of scholarship and history)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>michigan
        law review association</Value><Count>6</Count><AddAction>addfacetfilter(Publisher:michigan
        law review association)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>current
        medicine for attorneys</Value><Count>5</Count><AddAction>addfacetfilter(Publisher:current
        medicine for attorneys)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>university
        of southern california</Value><Count>4</Count><AddAction>addfacetfilter(Publisher:university
        of southern california)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>university
        of wisconsin law school</Value><Count>4</Count><AddAction>addfacetfilter(Publisher:university
        of wisconsin law school)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        york state bar association</Value><Count>3</Count><AddAction>addfacetfilter(Publisher:new
        york state bar association)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>cleveland
        state university</Value><Count>2</Count><AddAction>addfacetfilter(Publisher:cleveland
        state university)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>Language</Id><Label>Language</Label><AvailableFacetValues><AvailableFacetValue><Value>english</Value><Count>979718</Count><AddAction>addfacetfilter(Language:english)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>french</Value><Count>7570</Count><AddAction>addfacetfilter(Language:french)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>spanish</Value><Count>3248</Count><AddAction>addfacetfilter(Language:spanish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>chinese</Value><Count>1767</Count><AddAction>addfacetfilter(Language:chinese)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>turkish</Value><Count>1366</Count><AddAction>addfacetfilter(Language:turkish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>undetermined</Value><Count>775</Count><AddAction>addfacetfilter(Language:undetermined)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>portuguese</Value><Count>707</Count><AddAction>addfacetfilter(Language:portuguese)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>persian</Value><Count>665</Count><AddAction>addfacetfilter(Language:persian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>german</Value><Count>583</Count><AddAction>addfacetfilter(Language:german)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>polish</Value><Count>521</Count><AddAction>addfacetfilter(Language:polish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>russian</Value><Count>518</Count><AddAction>addfacetfilter(Language:russian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>romanian</Value><Count>401</Count><AddAction>addfacetfilter(Language:romanian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>czech</Value><Count>192</Count><AddAction>addfacetfilter(Language:czech)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>korean</Value><Count>174</Count><AddAction>addfacetfilter(Language:korean)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>italian</Value><Count>169</Count><AddAction>addfacetfilter(Language:italian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>croatian</Value><Count>119</Count><AddAction>addfacetfilter(Language:croatian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>serbian</Value><Count>102</Count><AddAction>addfacetfilter(Language:serbian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>arabic</Value><Count>76</Count><AddAction>addfacetfilter(Language:arabic)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>modern
        greek</Value><Count>59</Count><AddAction>addfacetfilter(Language:modern greek)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>multiple
        languages</Value><Count>36</Count><AddAction>addfacetfilter(Language:multiple
        languages)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>hebrew</Value><Count>27</Count><AddAction>addfacetfilter(Language:hebrew)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>slovenian</Value><Count>25</Count><AddAction>addfacetfilter(Language:slovenian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>afrikaans</Value><Count>21</Count><AddAction>addfacetfilter(Language:afrikaans)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>ukrainian</Value><Count>21</Count><AddAction>addfacetfilter(Language:ukrainian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>slovak</Value><Count>18</Count><AddAction>addfacetfilter(Language:slovak)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>lithuanian</Value><Count>17</Count><AddAction>addfacetfilter(Language:lithuanian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>swedish</Value><Count>15</Count><AddAction>addfacetfilter(Language:swedish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>bosnian</Value><Count>10</Count><AddAction>addfacetfilter(Language:bosnian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>japanese</Value><Count>10</Count><AddAction>addfacetfilter(Language:japanese)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>norwegian</Value><Count>10</Count><AddAction>addfacetfilter(Language:norwegian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>spanish;
        castilian</Value><Count>10</Count><AddAction>addfacetfilter(Language:spanish;
        castilian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>iranian
        languages</Value><Count>7</Count><AddAction>addfacetfilter(Language:iranian
        languages)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>greek,
        ancient (to 1453)</Value><Count>6</Count><AddAction>addfacetfilter(Language:greek\,
        ancient \(to 1453\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>northern
        sami</Value><Count>5</Count><AddAction>addfacetfilter(Language:northern sami)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>dutch/flemish</Value><Count>4</Count><AddAction>addfacetfilter(Language:dutch/flemish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>malay</Value><Count>3</Count><AddAction>addfacetfilter(Language:malay)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>thai</Value><Count>3</Count><AddAction>addfacetfilter(Language:thai)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>urdu</Value><Count>3</Count><AddAction>addfacetfilter(Language:urdu)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>catalan</Value><Count>2</Count><AddAction>addfacetfilter(Language:catalan)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>galician</Value><Count>2</Count><AddAction>addfacetfilter(Language:galician)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>indonesian</Value><Count>2</Count><AddAction>addfacetfilter(Language:indonesian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>latin</Value><Count>2</Count><AddAction>addfacetfilter(Language:latin)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>bulgarian</Value><Count>1</Count><AddAction>addfacetfilter(Language:bulgarian)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>dutch;
        flemish</Value><Count>1</Count><AddAction>addfacetfilter(Language:dutch; flemish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>finnish</Value><Count>1</Count><AddAction>addfacetfilter(Language:finnish)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>haitian
        creole</Value><Count>1</Count><AddAction>addfacetfilter(Language:haitian creole)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>tagalog</Value><Count>1</Count><AddAction>addfacetfilter(Language:tagalog)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>SubjectGeographic</Id><Label>Geography</Label><AvailableFacetValues><AvailableFacetValue><Value>united
        states</Value><Count>32814</Count><AddAction>addfacetfilter(SubjectGeographic:united
        states)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>great
        britain</Value><Count>8504</Count><AddAction>addfacetfilter(SubjectGeographic:great
        britain)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>china</Value><Count>2941</Count><AddAction>addfacetfilter(SubjectGeographic:china)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>japan</Value><Count>2711</Count><AddAction>addfacetfilter(SubjectGeographic:japan)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>canada</Value><Count>2682</Count><AddAction>addfacetfilter(SubjectGeographic:canada)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>australia</Value><Count>2499</Count><AddAction>addfacetfilter(SubjectGeographic:australia)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>europe</Value><Count>2121</Count><AddAction>addfacetfilter(SubjectGeographic:europe)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>england</Value><Count>2114</Count><AddAction>addfacetfilter(SubjectGeographic:england)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>california</Value><Count>2095</Count><AddAction>addfacetfilter(SubjectGeographic:california)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        york (state)</Value><Count>2083</Count><AddAction>addfacetfilter(SubjectGeographic:new
        york \(state\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>india</Value><Count>1500</Count><AddAction>addfacetfilter(SubjectGeographic:india)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>sweden</Value><Count>1430</Count><AddAction>addfacetfilter(SubjectGeographic:sweden)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        york (n.y.)</Value><Count>1252</Count><AddAction>addfacetfilter(SubjectGeographic:new
        york \(n.y.\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>germany</Value><Count>1216</Count><AddAction>addfacetfilter(SubjectGeographic:germany)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>italy</Value><Count>1216</Count><AddAction>addfacetfilter(SubjectGeographic:italy)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>taiwan</Value><Count>1173</Count><AddAction>addfacetfilter(SubjectGeographic:taiwan)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>netherlands</Value><Count>1127</Count><AddAction>addfacetfilter(SubjectGeographic:netherlands)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>france</Value><Count>1073</Count><AddAction>addfacetfilter(SubjectGeographic:france)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>denmark</Value><Count>968</Count><AddAction>addfacetfilter(SubjectGeographic:denmark)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>texas</Value><Count>946</Count><AddAction>addfacetfilter(SubjectGeographic:texas)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>massachusetts</Value><Count>904</Count><AddAction>addfacetfilter(SubjectGeographic:massachusetts)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>ontario</Value><Count>685</Count><AddAction>addfacetfilter(SubjectGeographic:ontario)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>pennsylvania</Value><Count>578</Count><AddAction>addfacetfilter(SubjectGeographic:pennsylvania)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>florida</Value><Count>550</Count><AddAction>addfacetfilter(SubjectGeographic:florida)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>illinois</Value><Count>499</Count><AddAction>addfacetfilter(SubjectGeographic:illinois)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>north
        carolina</Value><Count>439</Count><AddAction>addfacetfilter(SubjectGeographic:north
        carolina)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>maryland</Value><Count>419</Count><AddAction>addfacetfilter(SubjectGeographic:maryland)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        jersey</Value><Count>330</Count><AddAction>addfacetfilter(SubjectGeographic:new
        jersey)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>michigan</Value><Count>323</Count><AddAction>addfacetfilter(SubjectGeographic:michigan)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>ohio</Value><Count>302</Count><AddAction>addfacetfilter(SubjectGeographic:ohio)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>minnesota</Value><Count>262</Count><AddAction>addfacetfilter(SubjectGeographic:minnesota)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>georgia</Value><Count>244</Count><AddAction>addfacetfilter(SubjectGeographic:georgia)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>colorado</Value><Count>233</Count><AddAction>addfacetfilter(SubjectGeographic:colorado)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>connecticut</Value><Count>197</Count><AddAction>addfacetfilter(SubjectGeographic:connecticut)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>missouri</Value><Count>187</Count><AddAction>addfacetfilter(SubjectGeographic:missouri)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>tennessee</Value><Count>177</Count><AddAction>addfacetfilter(SubjectGeographic:tennessee)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>wisconsin</Value><Count>156</Count><AddAction>addfacetfilter(SubjectGeographic:wisconsin)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>virginia</Value><Count>147</Count><AddAction>addfacetfilter(SubjectGeographic:virginia)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>louisiana</Value><Count>141</Count><AddAction>addfacetfilter(SubjectGeographic:louisiana)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>iowa</Value><Count>138</Count><AddAction>addfacetfilter(SubjectGeographic:iowa)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>indiana</Value><Count>137</Count><AddAction>addfacetfilter(SubjectGeographic:indiana)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>kentucky</Value><Count>126</Count><AddAction>addfacetfilter(SubjectGeographic:kentucky)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>alaska</Value><Count>87</Count><AddAction>addfacetfilter(SubjectGeographic:alaska)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>alabama</Value><Count>86</Count><AddAction>addfacetfilter(SubjectGeographic:alabama)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>south
        carolina</Value><Count>84</Count><AddAction>addfacetfilter(SubjectGeographic:south
        carolina)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        hampshire</Value><Count>68</Count><AddAction>addfacetfilter(SubjectGeographic:new
        hampshire)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>kansas</Value><Count>61</Count><AddAction>addfacetfilter(SubjectGeographic:kansas)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>new
        york</Value><Count>29</Count><AddAction>addfacetfilter(SubjectGeographic:new
        york)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>district
        of columbia</Value><Count>25</Count><AddAction>addfacetfilter(SubjectGeographic:district
        of columbia)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>oklahoma</Value><Count>17</Count><AddAction>addfacetfilter(SubjectGeographic:oklahoma)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>CollectionLibrary</Id><Label>Collection</Label><AvailableFacetValues><AvailableFacetValue><Value>Fordham
        Urban Law Journal</Value><Count>4</Count><AddAction>addfacetfilter(CollectionLibrary:Fordham
        Urban Law Journal)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Faculty
        Scholarship</Value><Count>2</Count><AddAction>addfacetfilter(CollectionLibrary:Faculty
        Scholarship)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>PublicationYear</Id><Label>Publication
        Year</Label><AvailableFacetValues><AvailableFacetValue><Value>2015</Value><Count>93679</Count><AddAction>addfacetfilter(PublicationYear:2015)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2014</Value><Count>87256</Count><AddAction>addfacetfilter(PublicationYear:2014)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2013</Value><Count>83707</Count><AddAction>addfacetfilter(PublicationYear:2013)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2012</Value><Count>75445</Count><AddAction>addfacetfilter(PublicationYear:2012)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2016</Value><Count>74978</Count><AddAction>addfacetfilter(PublicationYear:2016)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2011</Value><Count>65475</Count><AddAction>addfacetfilter(PublicationYear:2011)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2010</Value><Count>60258</Count><AddAction>addfacetfilter(PublicationYear:2010)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2009</Value><Count>57076</Count><AddAction>addfacetfilter(PublicationYear:2009)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2008</Value><Count>54405</Count><AddAction>addfacetfilter(PublicationYear:2008)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2007</Value><Count>51518</Count><AddAction>addfacetfilter(PublicationYear:2007)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2006</Value><Count>42728</Count><AddAction>addfacetfilter(PublicationYear:2006)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2005</Value><Count>39912</Count><AddAction>addfacetfilter(PublicationYear:2005)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2004</Value><Count>39487</Count><AddAction>addfacetfilter(PublicationYear:2004)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2003</Value><Count>30980</Count><AddAction>addfacetfilter(PublicationYear:2003)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2002</Value><Count>22360</Count><AddAction>addfacetfilter(PublicationYear:2002)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2001</Value><Count>14021</Count><AddAction>addfacetfilter(PublicationYear:2001)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2000</Value><Count>11969</Count><AddAction>addfacetfilter(PublicationYear:2000)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1999</Value><Count>11281</Count><AddAction>addfacetfilter(PublicationYear:1999)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1998</Value><Count>8469</Count><AddAction>addfacetfilter(PublicationYear:1998)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1997</Value><Count>6596</Count><AddAction>addfacetfilter(PublicationYear:1997)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1996</Value><Count>5550</Count><AddAction>addfacetfilter(PublicationYear:1996)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1995</Value><Count>5018</Count><AddAction>addfacetfilter(PublicationYear:1995)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1994</Value><Count>4849</Count><AddAction>addfacetfilter(PublicationYear:1994)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1993</Value><Count>3738</Count><AddAction>addfacetfilter(PublicationYear:1993)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1992</Value><Count>2982</Count><AddAction>addfacetfilter(PublicationYear:1992)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1991</Value><Count>2283</Count><AddAction>addfacetfilter(PublicationYear:1991)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1990</Value><Count>1659</Count><AddAction>addfacetfilter(PublicationYear:1990)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1989</Value><Count>1361</Count><AddAction>addfacetfilter(PublicationYear:1989)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1988</Value><Count>951</Count><AddAction>addfacetfilter(PublicationYear:1988)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1987</Value><Count>827</Count><AddAction>addfacetfilter(PublicationYear:1987)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1985</Value><Count>797</Count><AddAction>addfacetfilter(PublicationYear:1985)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1986</Value><Count>775</Count><AddAction>addfacetfilter(PublicationYear:1986)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1984</Value><Count>607</Count><AddAction>addfacetfilter(PublicationYear:1984)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1981</Value><Count>473</Count><AddAction>addfacetfilter(PublicationYear:1981)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1980</Value><Count>466</Count><AddAction>addfacetfilter(PublicationYear:1980)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1983</Value><Count>466</Count><AddAction>addfacetfilter(PublicationYear:1983)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1982</Value><Count>407</Count><AddAction>addfacetfilter(PublicationYear:1982)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1979</Value><Count>374</Count><AddAction>addfacetfilter(PublicationYear:1979)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1978</Value><Count>332</Count><AddAction>addfacetfilter(PublicationYear:1978)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1977</Value><Count>306</Count><AddAction>addfacetfilter(PublicationYear:1977)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1976</Value><Count>292</Count><AddAction>addfacetfilter(PublicationYear:1976)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1975</Value><Count>274</Count><AddAction>addfacetfilter(PublicationYear:1975)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1974</Value><Count>147</Count><AddAction>addfacetfilter(PublicationYear:1974)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1973</Value><Count>89</Count><AddAction>addfacetfilter(PublicationYear:1973)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1972</Value><Count>67</Count><AddAction>addfacetfilter(PublicationYear:1972)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>2017</Value><Count>67</Count><AddAction>addfacetfilter(PublicationYear:2017)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1971</Value><Count>64</Count><AddAction>addfacetfilter(PublicationYear:1971)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1970</Value><Count>48</Count><AddAction>addfacetfilter(PublicationYear:1970)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1968</Value><Count>36</Count><AddAction>addfacetfilter(PublicationYear:1968)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>1967</Value><Count>30</Count><AddAction>addfacetfilter(PublicationYear:1967)</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet><AvailableFacet><Id>ContentProvider</Id><Label>Content
        Provider</Label><AvailableFacetValues><AvailableFacetValue><Value>Business
        Source Complete</Value><Count>61279</Count><AddAction>addfacetfilter(ContentProvider:Business
        Source Complete)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>JSTOR
        Journals</Value><Count>29462</Count><AddAction>addfacetfilter(ContentProvider:JSTOR
        Journals)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>LexisNexis
        Academic: Law Reviews</Value><Count>1812</Count><AddAction>addfacetfilter(ContentProvider:LexisNexis
        Academic\: Law Reviews)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>InfoTrac
        LegalTrac</Value><Count>1705</Count><AddAction>addfacetfilter(ContentProvider:InfoTrac
        LegalTrac)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>HeinOnline</Value><Count>349</Count><AddAction>addfacetfilter(ContentProvider:HeinOnline)</AddAction></AvailableFacetValue><AvailableFacetValue><Value>Index
        to Legal Periodicals Retrospective: 1908-1981 (H.W. Wilson)</Value><Count>113</Count><AddAction>addfacetfilter(ContentProvider:Index
        to Legal Periodicals Retrospective\: 1908-1981 \(H.W. Wilson\))</AddAction></AvailableFacetValue><AvailableFacetValue><Value>FLASH
        (Institutional Repository)</Value><Count>6</Count><AddAction>addfacetfilter(ContentProvider:FLASH
        \(Institutional Repository\))</AddAction></AvailableFacetValue></AvailableFacetValues></AvailableFacet></AvailableFacets><AvailableCriteria><DateRange><MinDate>1702-01</MinDate><MaxDate>2105-04</MaxDate></DateRange></AvailableCriteria></SearchResult></SearchResponseMessageGet>'
    http_version: 
  recorded_at: Mon, 24 Oct 2016 19:55:00 GMT
- request:
    method: get
    uri: http://eds-api.ebscohost.com/edsapi/rest/endsession?sessiontoken=f23796ef-26e8-4e9d-b754-401e6aa8a69d.uxX/9/HMGfN4XF%2BoChCc1bzpIqAg12j1r3tGpKTiLJg=
    body:
      encoding: UTF-8
      string: ''
    headers:
      X-Authenticationtoken:
      - ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0
      Accept:
      - application/xml
  response:
    status:
      code: 200
      message: OK
    headers:
      Cache-Control:
      - private
      Content-Length:
      - '179'
      Content-Type:
      - application/xml; charset=utf-8
      Server:
      - Microsoft-IIS/7.5
      X-Authenticationtoken:
      - ABwaI4lKTJacbcMoVc_x8JPbVI4keFgObht7IkN1c3RvbWVySWQiOiJzODk0NDc0MCIsIkdyb3VwSWQiOiJtYWluIn0
      X-Msg-Correlid:
      - 3b3cddb2-3134-4c3a-bc72-e2499488a867
      X-Aspnet-Version:
      - 4.0.30319
      X-Powered-By:
      - ASP.NET
      Date:
      - Mon, 24 Oct 2016 19:55:00 GMT
    body:
      encoding: UTF-8
      string: <EndSessionResponse xmlns="http://epnet.com/webservices/EbscoApi/Contracts"
        xmlns:i="http://www.w3.org/2001/XMLSchema-instance"><IsSuccessful>y</IsSuccessful></EndSessionResponse>
    http_version: 
  recorded_at: Mon, 24 Oct 2016 19:55:01 GMT
recorded_with: VCR 2.9.3
